Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

NCT00025675 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

105

Enrollment

OTHER

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: gefitinib

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]